您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:诺信 2023年度报告 - 发现报告

诺信 2023年度报告

2024-12-18美股财报米***
诺信 2023年度报告

(Mark One)☐ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934For the fiscal year ended October 31, 2024OR˗TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934For the transition period fromtoCommission file number0-7977NORDSON CORPORATION(Exact name of Registrant as specified in its charter)Ohio(State or other jurisdiction of incorporation or organization28601 Clemens Road Westlake, Ohio(Address of principal executive offices)34-0590250(I.R.S. Employer Identification No.)44145(Zip Code)(440) 892-1580(Registrant’s Telephone Number, including area code)Securities registered pursuant to Section 12(b) of the Act:Title of Each ClassTrading Symbol(s)Name of Each Exchange on whichRegisteredCommon Shares, without parvalueNDSNNasdaq Stock Market LLCSecurities registered pursuant to Section 12(g) of the Act:None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the SecuritiesAct.Yes xNo☐ Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of theAct.Yes☐No x Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrantwasrequired to file such reports),and(2)has been subject to such filing requirements for the past 90days.Yes xNo☐ Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the Registrant was required to submit such files).Yes xNo☐ Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act: If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act☐ Indicate by check mark whether the Registrant has filed a report on and attestation to its management’s assessmentof the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect the correction of an error to previously issued financialstatements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recoveryperiod pursuant to §240.10D-1(b).☐ Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the ExchangeAct).Yes☐No☐ The aggregate market value of Common Shares, no par value per share, held by nonaffiliates (based on the closingsale price on the Nasdaq Stock Market) as of April 30, 2024 was approximately $14,758,563,021. There were 57,016,026 Common Shares outstanding as of November 30, 2024. Documents incorporated by reference:Portions of the Definitive Proxy Statement for the 2025 Annual Meeting of Shareholders - Part III of the Form 10-K Table of Contents Table of Contents Table of Contents Table of Contents PART I NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES In this annual report, all amounts related to United States dollars and foreign currency and to the numberof Nordson Corporation’s common shares, except for per share earnings and dividend amounts, areexpressed in thousands unless otherwise indicated. Unless the context otherwise indicates, all referencesto “we,” “us,” “our,” or the “Company” mean Nordson Corporation. Unless otherwise noted, all references to years relate to our fiscal year ending October 31. Item 1. Business General Description of Business Nordson is an innovative precision technology company that leverages a scalable growth framework todelivertop tier growth with leading margins and returns.We engineer,manufacture and marketdifferentiated products and systems used for precision dispensing, applying and controlling of adhesives,coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treatand cure surfaces and various medical products such as: catheters, cannulas, medical balloons andmedical tubing. These products are supported with exten